MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qai.0b013e318266ee3f

Медицинская библиотека · Journal of acquired immune deficiency syndromes (1999) · 2012

Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.

Johnston Victoria, Fielding Katherine L, Charalambous Salome, Churchyard Gavin, Phillips Andrew, Grant Alison D

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Without resistance tests, deciding which patients with virological failure should switch to second-line antiretroviral therapy (ART) is difficult. The factors influencing this decision are poorly understood. We assess predictors of switching regimens after virological failure.

DESIGN

Retrospective cohort study using clinical data from a South African ART program with 6-monthly viral load (VL) monitoring.

METHODS

We constructed a dataset of patient visits occurring following first-line virological failure, and used random effects logistic regression (accounting for individual-level and clinic-level clustering) to assess predictors of switching at each visit.

RESULTS

One thousand six hundred sixty-eight patients with virological failure (73% male, mean age 41 years, median CD4 184 cells/mm, mean log10 VL 4.3) contributed 1922 person-years of viremia. 12 months after failure, the cumulative incidence of switching regimen, viral resuppression, or death was 16.9%, 13.2%, and 4.6%, respectively. In adjusted analysis, switching was more likely at the third or subsequent visit after failure; in visits occurring in 2008 versus 2003 to 2007; and in patients with ART experience pre-programme, current high VL or low CD4 count. Switching was less likely in patients with no clinic contact for 4 months, or declining VL. Switching rates varied between clinics with clinic-level clustering evident in the final model (P <0.001).

CONCLUSIONS

Despite 6-monthly virological monitoring and recommendations to switch after adherence interventions and confirmed viremia, patients experienced delayed switching. Individual-level covariates influenced switching but did not account for variable switching rates between clinics, suggesting differences in guideline implementation. In certain circumstances delays may be warranted; however understanding barriers to guideline implementation will limit unnecessary delays.

Для цитирования: Johnston Victoria, Fielding Katherine L, Charalambous Salome, Churchyard Gavin, Phillips Andrew, Grant Alison D. Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.. Journal of acquired immune deficiency syndromes (1999). 2012. DOI: 10.1097/qai.0b013e318266ee3f.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.